Bloomington-based Donaldson made a key acquisition late in its fourth quarter to support its recently created life sciences sector and then entered into a big-name partnership just after the fiscal year ended.
But the company didn't need those blockbuster moves to see a record annual profit.
The company's traditional business of supplying technology-led filtration products for industrial and mobile applications helped Donaldson earn $358.8 million or $2.90 a share. Compared with $332.8 million or $2.66 a share last year, earnings increased 7.8% and adjusted earnings per share (EPS) 9%.
For just the fourth quarter, the company made 75 cents a share, down 7.4% from a year ago on revenue of $879.5 million, down 1.2%. EPS for the fourth quarter was 78 cents and $3.04 for the year compared with 84 cents and $2.68 cents a share in the same period a year ago. Adjusted EPS for the quarter and year met analysts' expectations.
Revenue for the year grew 3.8% to $3.4 billion. Donaldson's revenue includes a mix of first-fit projects, but approximately 75% of revenue comes from the sale of aftermarket replacement parts.
The life sciences sector is imperative to Donaldson's future, as the company expects categories in that sector to grow faster and have higher margins than their traditional business.
Donaldson officials said during their investor day conference earlier this year they'd continue to make investments in their new life sciences segment. On June 29, they announced they acquired Univercells Technologies, which provides biomanufacturing technologies for companies that produce cell and gene therapies.
Donaldson paid approximately $148 million for the Belgium-based company with 100 employees that did about $10.8 million in revenue the previous year.